Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Saved in:
| Title: | Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. |
|---|---|
| Authors: | Payne AB; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: bvx2@cdc.gov., Watts JA; Westat, Rockville, MD, USA., Mitchell PK; Westat, Rockville, MD, USA., Dascomb K; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA., Irving SA; Kaiser Permanente Center for Health Research, Portland, OR, USA., Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, CA, USA., Grannis SJ; Indiana University School of Medicine, Indianapolis, IN, USA; Regenstrief Institute Center for Biomedical Informatics, Indianapolis, IN, USA., Ong TC; University of Colorado School of Medicine, Aurora, CO, USA., Ball SW; Westat, Rockville, MD, USA., DeSilva MB; HealthPartners Institute, Minneapolis, MN, USA., Natarajan K; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA., Sheffield T; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA., Bride D; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA., Arndorfer J; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA., Naleway AL; Kaiser Permanente Center for Health Research, Portland, OR, USA., Koppolu P; Kaiser Permanente Center for Health Research, Portland, OR, USA., Fireman B; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, CA, USA., Zerbo O; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, CA, USA., Timbol J; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, CA, USA., Goddard K; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, CA, USA., Dixon BE; Regenstrief Institute Center for Biomedical Informatics, Indianapolis, IN, USA; Department of Health Policy and Management, Richard M Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA., Fadel WF; Regenstrief Institute Center for Biomedical Informatics, Indianapolis, IN, USA; Department of Biostatistics and Health Data Science, Richard M Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA., Rogerson C; Regenstrief Institute Center for Biomedical Informatics, Indianapolis, IN, USA; Department of Pediatrics, School of Medicine, Indiana University, Indianapolis, IN, USA., Allen KS; Regenstrief Institute Center for Biomedical Informatics, Indianapolis, IN, USA; Department of Health Policy and Management, Richard M Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA., Rao S; University of Colorado School of Medicine, Aurora, CO, USA., Mayer D; University of Colorado School of Medicine, Aurora, CO, USA., Barron M; University of Colorado School of Medicine, Aurora, CO, USA., Reese SE; Westat, Rockville, MD, USA., Rowley EAK; Westat, Rockville, MD, USA., Najdowski M; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Eagle Health Analytics, San Antonio, TX, USA., Ciesla AA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Eagle Health Analytics, San Antonio, TX, USA., Mak J; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Reeves EL; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Akinsete OO; HealthPartners Institute, Minneapolis, MN, USA., McEvoy CE; HealthPartners Institute, Minneapolis, MN, USA., Essien IJ; HealthPartners Institute, Minneapolis, MN, USA., Tenforde MW; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Fleming-Dutra KE; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Link-Gelles R; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; United States Public Health Service Commissioned Corps, Rockville, MD, USA. |
| Source: | Lancet (London, England) [Lancet] 2024 Oct 19; Vol. 404 (10462), pp. 1547-1559. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
